0001724209-17-000001.txt : 20171201 0001724209-17-000001.hdr.sgml : 20171201 20171201154856 ACCESSION NUMBER: 0001724209-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171201 DATE AS OF CHANGE: 20171201 EFFECTIVENESS DATE: 20171201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ReversingLabs LLC CENTRAL INDEX KEY: 0001724209 IRS NUMBER: 453696590 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-299915 FILM NUMBER: 171234157 BUSINESS ADDRESS: STREET 1: 189 CAMBRIDGE ST., SUITE 4 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 6172507518 MAIL ADDRESS: STREET 1: 189 CAMBRIDGE ST., SUITE 4 CITY: CAMBRIDGE STATE: MA ZIP: 02141 D 1 primary_doc.xml X0708 D LIVE 0001724209 ReversingLabs LLC 189 CAMBRIDGE ST., SUITE 4 CAMBRIDGE MA MASSACHUSETTS 02141 6172507518 DELAWARE None None Limited Liability Company true Mario Vuksan 189 Cambridge St. Suite 4 Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Chief Executive Officer Tomislav Pericin 189 Cambridge St. Suite 4 Cambridge MA MASSACHUSETTS 02141 Director Computers Decline to Disclose 06b false 2017-11-07 false true false 0 25000000 25000000 0 The Investors purchased Series A Preferred Units in ReversingLabs LLC (the "Company") for an aggregate purchase price of $25,000,000. $7,500,000 of the proceeds were used by the Company to redeem Common Units for certain members of the Company. false 3 0 0 7500000 true false ReversingLabs LLC Mario Vuksan Mario Vuksan Chief Executive Officer 2017-11-25